SCHEMBL7654053

SCHEMBL7654053

N#CC(C#N)=C1N(CCN(Cc2cccc(CN3CCCCC3)c2)C(=O)c2ccccc2)CCN1Cc1cccc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.60
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HIF1A Q16665 1/20 0.40
NPFFR1 Q9GZQ6 4/20 0.39
NPFFR2 Q9Y5X5 4/20 0.39
OPRM1 P35372 3/20 0.39
OPRK1 P41145 3/20 0.39
OPRD1 P41143 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
OPRL1 P41146 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665094 0.92 HRH3 (0.60) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7664398 0.92 HRH3 (0.56) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7656593 0.91 HRH3 (0.55) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7657287 0.89 HRH3 (0.64) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7656338 0.88 HRH3 (0.66) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7654067 0.87 HRH3 (0.60) HRH3NPFFR1NPFFR2OPRM1OPRK1
SCHEMBL7661605 0.87 HRH3 (0.64) HRH3NPFFR1NPFFR2OPRM1OPRK1
SCHEMBL7656388 0.85 HRH3 (0.65) HRH3NPFFR1NPFFR2OPRM1OPRK1
SCHEMBL7662209 0.85 HRH3 (0.59) HRH3CYP2D6CYP2C9HIF1ANPFFR1
SCHEMBL7663832 0.80 HRH3 (0.66) HRH3NPFFR1NPFFR2OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085861-A1 IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-31 WO disclosed
US-6469002-B1 COMPOUNDS WHICH MODULATE CHEMOKINE RECEPTOR ACTIVITY AND ARE USEFUL IN TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. 2002-10-22 US disclosed